Omnicell, Inc. (OMCL)
USD 31.08
(1.27%)
USD 31.08
(1.27%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.03 Billion USD | -3.95% |
| 2022 | 1.08 Billion USD | 8.52% |
| 2021 | 995.8 Million USD | 16.2% |
| 2020 | 857 Million USD | 116.66% |
| 2019 | 395.55 Million USD | -1.51% |
| 2018 | 401.62 Million USD | -13.28% |
| 2017 | 463.1 Million USD | -8.02% |
| 2016 | 503.49 Million USD | 185.49% |
| 2015 | 176.35 Million USD | 3.67% |
| 2014 | 170.11 Million USD | 18.0% |
| 2013 | 144.16 Million USD | 5.89% |
| 2012 | 136.14 Million USD | 72.22% |
| 2011 | 79.05 Million USD | 1.6% |
| 2010 | 77.81 Million USD | -1.55% |
| 2009 | 79.03 Million USD | 4.63% |
| 2008 | 75.53 Million USD | 2.37% |
| 2007 | 73.78 Million USD | 14.16% |
| 2006 | 64.63 Million USD | 43.03% |
| 2005 | 45.19 Million USD | -1.32% |
| 2004 | 45.79 Million USD | -7.88% |
| 2003 | 49.7 Million USD | 0.96% |
| 2002 | 49.23 Million USD | -6.24% |
| 2001 | 52.51 Million USD | -23.82% |
| 2000 | 68.92 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.09 Billion USD | 5.51% |
| 2024 Q3 | 1.07 Billion USD | -1.52% |
| 2024 Q2 | 1.08 Billion USD | -0.58% |
| 2023 Q2 | 1.03 Billion USD | -7.04% |
| 2023 Q1 | 1.1 Billion USD | 2.56% |
| 2023 Q4 | 1.03 Billion USD | 0.37% |
| 2023 Q3 | 1.03 Billion USD | 0.37% |
| 2023 FY | 1.03 Billion USD | -3.95% |
| 2022 Q2 | 1.03 Billion USD | -0.86% |
| 2022 Q1 | 1.04 Billion USD | 5.23% |
| 2022 Q3 | 1.04 Billion USD | 0.53% |
| 2022 Q4 | 1.08 Billion USD | 3.48% |
| 2022 FY | 1.08 Billion USD | 8.52% |
| 2021 FY | 995.8 Million USD | 16.2% |
| 2021 Q1 | 875.61 Million USD | 2.17% |
| 2021 Q2 | 908.42 Million USD | 3.75% |
| 2021 Q3 | 940.13 Million USD | 3.49% |
| 2021 Q4 | 995.8 Million USD | 5.92% |
| 2020 FY | 857 Million USD | 116.66% |
| 2020 Q1 | 353.14 Million USD | -10.72% |
| 2020 Q2 | 334.98 Million USD | -5.14% |
| 2020 Q3 | 800.87 Million USD | 139.08% |
| 2020 Q4 | 857 Million USD | 7.01% |
| 2019 Q1 | 446.57 Million USD | 11.19% |
| 2019 FY | 395.55 Million USD | -1.51% |
| 2019 Q2 | 423.73 Million USD | -5.11% |
| 2019 Q3 | 436.73 Million USD | 3.07% |
| 2019 Q4 | 395.55 Million USD | -9.43% |
| 2018 FY | 401.62 Million USD | -13.28% |
| 2018 Q4 | 401.62 Million USD | -7.28% |
| 2018 Q3 | 433.13 Million USD | -1.07% |
| 2018 Q2 | 437.83 Million USD | -6.14% |
| 2018 Q1 | 466.45 Million USD | 0.72% |
| 2017 Q3 | 451.32 Million USD | -1.97% |
| 2017 Q4 | 463.1 Million USD | 2.61% |
| 2017 FY | 463.1 Million USD | -8.02% |
| 2017 Q1 | 470.82 Million USD | -6.49% |
| 2017 Q2 | 460.39 Million USD | -2.21% |
| 2016 Q1 | 513.26 Million USD | 191.04% |
| 2016 Q3 | 503.85 Million USD | 0.72% |
| 2016 FY | 503.49 Million USD | 185.49% |
| 2016 Q2 | 500.22 Million USD | -2.54% |
| 2016 Q4 | 503.49 Million USD | -0.07% |
| 2015 Q2 | 201.67 Million USD | 21.88% |
| 2015 Q3 | 185.18 Million USD | -8.18% |
| 2015 Q1 | 165.47 Million USD | -2.73% |
| 2015 Q4 | 176.35 Million USD | -4.76% |
| 2015 FY | 176.35 Million USD | 3.67% |
| 2014 Q1 | 145.22 Million USD | 0.74% |
| 2014 FY | 170.11 Million USD | 18.0% |
| 2014 Q3 | 168.41 Million USD | 5.5% |
| 2014 Q4 | 170.11 Million USD | 1.01% |
| 2014 Q2 | 159.63 Million USD | 9.92% |
| 2013 Q3 | 147.37 Million USD | 6.49% |
| 2013 Q1 | 135.56 Million USD | -0.43% |
| 2013 FY | 144.16 Million USD | 5.89% |
| 2013 Q4 | 144.16 Million USD | -2.18% |
| 2013 Q2 | 138.39 Million USD | 2.09% |
| 2012 Q4 | 136.14 Million USD | 8.49% |
| 2012 Q2 | 128.73 Million USD | 55.03% |
| 2012 Q1 | 83.03 Million USD | 5.04% |
| 2012 FY | 136.14 Million USD | 72.22% |
| 2012 Q3 | 125.48 Million USD | -2.52% |
| 2011 FY | 79.05 Million USD | 1.6% |
| 2011 Q4 | 79.05 Million USD | -1.84% |
| 2011 Q3 | 80.53 Million USD | 2.96% |
| 2011 Q2 | 78.22 Million USD | 0.2% |
| 2011 Q1 | 78.06 Million USD | 0.07% |
| 2010 FY | 77.81 Million USD | -1.55% |
| 2010 Q2 | 77.05 Million USD | -4.98% |
| 2010 Q3 | 77.79 Million USD | 0.97% |
| 2010 Q4 | 78.01 Million USD | 0.27% |
| 2010 Q1 | 81.08 Million USD | 1.41% |
| 2009 Q1 | 71.22 Million USD | -5.02% |
| 2009 FY | 79.03 Million USD | 4.63% |
| 2009 Q2 | 75.4 Million USD | 5.87% |
| 2009 Q3 | 78.57 Million USD | 4.21% |
| 2009 Q4 | 79.95 Million USD | 1.75% |
| 2008 Q3 | 74.93 Million USD | -1.5% |
| 2008 FY | 75.53 Million USD | 2.37% |
| 2008 Q1 | 82.22 Million USD | 11.44% |
| 2008 Q2 | 76.07 Million USD | -7.47% |
| 2008 Q4 | 74.98 Million USD | 0.06% |
| 2007 Q1 | 57.18 Million USD | -11.52% |
| 2007 Q4 | 73.78 Million USD | 14.17% |
| 2007 Q3 | 64.62 Million USD | 3.21% |
| 2007 Q2 | 62.61 Million USD | 9.5% |
| 2007 FY | 73.78 Million USD | 14.16% |
| 2006 Q4 | 64.63 Million USD | 9.93% |
| 2006 Q3 | 58.79 Million USD | 13.96% |
| 2006 Q2 | 51.59 Million USD | 11.21% |
| 2006 FY | 64.63 Million USD | 43.03% |
| 2006 Q1 | 46.39 Million USD | 2.66% |
| 2005 FY | 45.19 Million USD | -1.32% |
| 2005 Q1 | 45.79 Million USD | 0.01% |
| 2005 Q2 | 44.51 Million USD | -2.81% |
| 2005 Q3 | 50.89 Million USD | 14.34% |
| 2005 Q4 | 45.19 Million USD | -11.21% |
| 2004 Q4 | 45.79 Million USD | -4.14% |
| 2004 Q3 | 47.77 Million USD | -4.79% |
| 2004 FY | 45.79 Million USD | -7.88% |
| 2004 Q2 | 50.17 Million USD | 2.01% |
| 2004 Q1 | 49.18 Million USD | -1.05% |
| 2003 Q2 | 44.56 Million USD | 0.73% |
| 2003 Q3 | 42.36 Million USD | -4.94% |
| 2003 Q4 | 49.7 Million USD | 17.33% |
| 2003 FY | 49.7 Million USD | 0.96% |
| 2003 Q1 | 44.24 Million USD | -10.14% |
| 2002 Q3 | 48.35 Million USD | 6.73% |
| 2002 FY | 49.23 Million USD | -6.24% |
| 2002 Q2 | 45.31 Million USD | -1.3% |
| 2002 Q1 | 45.9 Million USD | -12.58% |
| 2002 Q4 | 49.23 Million USD | 1.81% |
| 2001 FY | 52.51 Million USD | -23.82% |
| 2001 Q4 | 52.51 Million USD | -0.83% |
| 2001 Q3 | 52.95 Million USD | -28.7% |
| 2001 Q2 | 74.26 Million USD | 1.14% |
| 2001 Q1 | 73.42 Million USD | 0.0% |
| 2000 FY | 68.92 Million USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| iCoreConnect Inc. | 11.24 Million USD | -9132.281% |
| Accolade, Inc. | 342.68 Million USD | -202.879% |
| Augmedix, Inc. | 43.39 Million USD | -2292.026% |
| BrightSpring Health Services, Inc. Common Stock | 5.17 Billion USD | 79.955% |
| CareCloud, Inc. | 37.79 Million USD | -2646.049% |
| CareCloud, Inc. | 37.79 Million USD | -2646.049% |
| Definitive Healthcare Corp. | 626.72 Million USD | -65.61% |
| Health Catalyst, Inc. | 334.89 Million USD | -209.925% |
| HealthEquity, Inc. | 1.2 Billion USD | 13.613% |
| HealthStream, Inc. | 159.19 Million USD | -552.003% |
| Inovalon Holdings, Inc. | 1.26 Billion USD | 17.8% |
| Nutex Health, Inc. | 319.13 Million USD | -225.226% |
| OneMedNet Corporation | 13.32 Million USD | -7690.665% |
| Progyny, Inc. | 203.19 Million USD | -410.812% |
| Renalytix Plc | 15.82 Million USD | -6458.347% |
| Schrödinger, Inc. | 254.39 Million USD | -307.994% |
| Simulations Plus, Inc. | 14.2 Million USD | -7205.208% |
| Streamline Health Solutions, Inc. | 22.92 Million USD | -4427.279% |
| SOPHiA GENETICS SA | 54.71 Million USD | -1796.999% |
| Ontrak, Inc. | 5.57 Million USD | -18517.471% |
| Minerva Surgical, Inc. | 51.71 Million USD | -1906.852% |
| GE HealthCare Technologies Inc. | 25.14 Billion USD | 95.872% |
| Sharecare, Inc. | 125.56 Million USD | -726.603% |
| Aclarion, Inc. | 3.18 Million USD | -32459.574% |
| CareMax, Inc. | 561.85 Million USD | -84.731% |
| Bullfrog AI Holdings, Inc. Common Stock | 184.35 Thousand USD | -562918.172% |
| Forian Inc. | 33.19 Million USD | -3026.619% |
| Bullfrog AI Holdings, Inc. Warrants | 184.35 Thousand USD | -562918.172% |
| HeartBeam, Inc. | 1.19 Million USD | -86828.308% |
| GeneDx Holdings Corp. | 245.65 Million USD | -322.509% |
| SCWorx Corp. | 2.42 Million USD | -42705.12% |
| 10x Genomics, Inc. | 224.1 Million USD | -363.152% |
| Zhongchao Inc. | 3.37 Million USD | -30621.69% |
| MSP Recovery, Inc. | 1.74 Billion USD | 40.379% |
| R1 RCM Inc. | 2.2 Billion USD | 53.01% |
| Spok Holdings, Inc. | 63.91 Million USD | -1523.964% |
| Privia Health Group, Inc. | 392.51 Million USD | -164.432% |
| EUDA Health Holdings Limited | 8.79 Million USD | -11704.727% |
| TruBridge, Inc. | 247.8 Million USD | -318.849% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.17 Billion USD | 79.955% |
| Sharecare, Inc. | 125.56 Million USD | -726.603% |
| GoodRx Holdings, Inc. | 826.84 Million USD | -25.529% |
| Premier, Inc. | 1.46 Billion USD | 29.218% |
| Certara, Inc. | 516.29 Million USD | -101.031% |
| GeneDx Holdings Corp. | 245.65 Million USD | -322.509% |
| Ontrak, Inc. | 5.57 Million USD | -18517.471% |
| SHL Telemedicine Ltd. | 36.58 Million USD | -2736.771% |
| CareCloud, Inc. | 37.79 Million USD | -2646.049% |
| EUDA Health Holdings Limited | 8.79 Million USD | -11704.727% |
| HeartBeam, Inc. | 1.19 Million USD | -86828.308% |
| Mangoceuticals, Inc. | 276.03 Thousand USD | -375906.289% |
| CareMax, Inc. | 561.85 Million USD | -84.731% |
| Healthcare Triangle, Inc. | 9.51 Million USD | -10812.88% |
| National Research Corporation | 73.48 Million USD | -1312.487% |
| Aclarion, Inc. | 3.18 Million USD | -32459.574% |
| OptimizeRx Corporation | 56.82 Million USD | -1726.665% |